For 6 years Tel Aviv University scientists have studied how certain viruses (bacteriophages) take control of dangerous antibiotic resistant bacteria (see ). They found that a virus protein uses a DNA-repair protein in the bacteria to "cunningly" cut the bacteria's DNA during repairs.
Doctors at Israel’s Beilinson Hospital monitored 102 cancer patients after inoculation with two shots of the Pfizer coronavirus vaccine. Only 10 failed to generate an antibody response. It should calm the fears of patients who have been self-isolating even after vaccination.
Israel has honored its health system personnel and partner agencies for their work in defeating Covid-19 in Israel. Speakers at the Jerusalem Theater event included Israel’s Prime Minister, Health Minister, Austria’s Prime Minister and the CEO of Pfizer.
Israel’s Bonus BioGroup (see previously) tested its MesenCure MSC treatment on 10 severely ill, high risk Covid-19 patients at Haifa’s Rambam hospital. All ten improved sufficiently to be discharged just one day after treatment. MesenCure now advances to Phase 2 trials.
It’s official. Researchers at the Hebrew University of Jerusalem have published the findings of their longevity study of 1200 Israelis that began in 1990. Participants aged 85-90 with a high optimism score had a 20% higher rate of survival over those who were less optimistic.
Israeli startup Cell-El Therapeutics.is developing a diagnostic tool for “triple A” (autoimmune antibody associated) autism. It has identified 30 immunological biomarkers and is developing a blood test using the best five. This could help identify severely autistic children and implement early therapies.
The Nerivio therapeutic wearable for treating migraine pain from Israel’s Theranica (see previously) won “Best New Technology Solution for Pain Management” award in the 2021 MedTech Breakthrough Awards program. It beat more than 3,850 nominations from 17 countries.
Israel’s CorrActions is developing technology to detect deterioration in human cognitive state from drowsiness, fatigue, exhaustion, intoxication, age, and health issues. A sensor monitors slight, unique, changes in human touch or motion. It could prevent accidents or work errors by professionals.
The development of CRISPR technology to prevent genetic diseases is hampered by off-target (unintended) changes to the genes. New software called CRISPECTOR from Israel’s IDC and Bar-Ilan University can prevent the consequences from transplanting erroneously modified cells.
Scientists at Israel’s Weizmann Institute have discovered that the dendritic immune cell cDC1 increases the severity of fatty liver disease and NASH, suffered by 90% of obese individuals. The discovery may lead to treatments that could benefit millions of patients.